3Helms M, Simonsen J, Molbak K. Quinolone resis-tance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis 2004, 190:1652-1654
4Centers for Disease Control and Prevention (CDC).Outbreak of multidrug-resistant Salmonella typhimurium associated with rodents purchased at retail pet stores-United States. MMWR Morb Mortal Wkly Rep 2005, 54:429-433
二级参考文献9
1[1]Ling JM, Chan EM, Lam AW, et al. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob Agents Chemother, 2003, 47:3567-3573
2[2]Griggs DJ, Gensberg K, Piddock LJV. Mutations in gyrA gene of quinolone-resistant salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother, 1996, 40:1009-1013
3[3]Heisig P. Genetic evidence for role of parC mutations in development of high-level fluoroquinolone resistance in escherichia coli. Antimicrob Agents Chemother, 1996, 40:879-885
4[4]Kim JH, Cho EH, Kim KS, et al. Cloning and nucleotide sequence of the DNA gyrAse gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates. Antimicrob Agents Chemother, 1998, 42:190-193
5[5]Weigel LM, Steward CD, Tenover FC. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.Antimicrob Agents Chemother, 1998, 42: 2661-2667
6[6]Deguchi TA, Fukuoka M, Yasuda, et al. Alteration in the GyrA subunit of DNA gyrAse and ParC subunit of topoisomerase Ⅳ in quinoloneresistant clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother, 1997, 41:699-701
7[7]Tankovic J, Bachoual R, Ouabdesselam S. et al. In vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gramnegative bacilli and Enterococcus faecalis. J Antimicrob Chemother,1999, 43:19-23
8[8]Hiasa H. The Glu-84 of ParC subunit plays critical roles in both topoisomerase Ⅳ-quinolone and topoisomerase Ⅳ-DNA interactions.Biochemistry, 2002, 41:11779-11785
9[9]Gensberg K, Jin YF, Piddock LJV. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium.FEMS Microbiol Lett, 1995, 132:57-60
3Centers for Disease Control and Prevention(CDC).Outbreak of multidrug-resistant Salmonella typhimurium associated with rodents purchased atretail pet stores-United States December 2003-October 2004[J].MMWR Morb Mortal Wkly Rep,2005,54(17):429-433.
5el-Ghodban A,Ghenghesh KS,Marialigeti K,et al.Serotypes,virulence factors,antibiotic sensitivity,beta-lactamase activity and plasmid analysis of Salmonella from children with diarrhea in Tripoli(Libya)[J].Acta Microbiol Immunol Hung,2002,49(4):433.
6Mlisana K,Auld SC,Grobler A,van Loggerenberg F,Williamson C,Iriogbe I,Sobieszczyk ME,Abdool Karim SS.Anaemia in Acute HIV-1 Subtype C Infection.PLoS ONE 2008;3:e1626
7Chakravarty J,Mehta H,Parekh A,Attili SV,Agrawal NR,Singh SP,Sundar S.Study on clinico-epidemiological profile of HIV patients in eastern India.J Assoc Physicians India 2006;54:854-857
8Diouf A,Seydi M,Diop BM,Soumaré M,Ndour CT,Manga NM,Dia Badiane NM,Diop SA,Sow PS.Epidemiological and clinical features of HIV-2 infection in Dakar.Med Mal Infect 2007;37:584-589
9Barnert J,Messmann H.Management of lower gastrointestinal tract bleeding.Best Pract Res Clin Gastroenterol 2008;22:295-312
10Orenstein JM,Kotler DP.Diarrheogenic bacterial enteritis in acquired immune deficiency syndrome:a light and electron microscopy study of 52 cases.Hum Pathol 1995;26:481-492